For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Humana Inc (NYSE: HUM) was $288.25 for the day, up 0.37% from the previous closing price of $287.19. In other words, the price has increased by $0.37 from its previous closing price. On the day, 1.51 million shares were traded. HUM stock price reached its highest trading level at $292.025 during the session, while it also had its lowest trading level at $285.21.
Ratios:
Our analysis of HUM’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.69.
On November 06, 2024, BofA Securities Upgraded its rating to Neutral which previously was Underperform and also upped its target price recommendation from $247 to $308.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 14 ’25 when Rechtin James A. bought 6,530 shares for $229.25 per share. The transaction valued at 1,496,984 led to the insider holds 30,474 shares of the business.
Diamond Susan M bought 10,959 shares of HUM for $2,732,134 on Apr 08 ’25. On Feb 24 ’25, another insider, Huval Timothy S., who serves as the Former Chief Administrative Of of the company, bought 1,247 shares for $258.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 34668404736 and an Enterprise Value of 25814863872. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.12, and their Forward P/E ratio for the next fiscal year is 21.02. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.22. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.28 while its Price-to-Book (P/B) ratio in mrq is 1.90. Its current Enterprise Value per Revenue stands at 0.21 whereas that against EBITDA is 6.43.
Stock Price History:
The Beta on a monthly basis for HUM is 0.44, which has changed by -0.19611233 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $382.72, while it has fallen to a 52-week low of $206.87. The 50-Day Moving Average of the stock is 17.89%, while the 200-Day Moving Average is calculated to be 10.58%.
Shares Statistics:
HUM traded an average of 1.76M shares per day over the past three months and 1486880 shares per day over the past ten days. A total of 120.27M shares are outstanding, with a floating share count of 119.99M. Insiders hold about 0.23% of the company’s shares, while institutions hold 95.22% stake in the company. Shares short for HUM as of 1753920000 were 4682779 with a Short Ratio of 2.67, compared to 1751241600 on 4322192. Therefore, it implies a Short% of Shares Outstanding of 4682779 and a Short% of Float of 4.37.
Dividends & Splits
With its trailing 12-month dividend rate of 3.54, HUM has a forward annual dividend rate of 3.54. Against a Trailing Annual Dividend Yield of 0.012326335The stock’s 5-year Average Dividend Yield is 0.82. The current Payout Ratio is 35.45% for HUM, which recently paid a dividend on 2025-06-27 with an ex-dividend date of 2025-06-27. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.
Earnings Estimates
Humana Inc (HUM) is presently subject to a detailed evaluation by 22.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$3.73, with high estimates of -$2.74 and low estimates of -$4.43.
Analysts are recommending an EPS of between $17.26 and $16.18 for the fiscal current year, implying an average EPS of $16.9. EPS for the following year is $13.66, with 24.0 analysts recommending between $15.85 and $10.42.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 15 analysts. It ranges from a high estimate of $32.2B to a low estimate of $31.4B. As of the current estimate, Humana Inc’s year-ago sales were $29.4BFor the next quarter, 15 analysts are estimating revenue of $31.84B. There is a high estimate of $32.38B for the next quarter, whereas the lowest estimate is $31.07B.
A total of 18 analysts have provided revenue estimates for HUM’s current fiscal year. The highest revenue estimate was $129.03B, while the lowest revenue estimate was $126.97B, resulting in an average revenue estimate of $128.17B. In the same quarter a year ago, actual revenue was $117.76BBased on 18 analysts’ estimates, the company’s revenue will be $134.39B in the next fiscal year. The high estimate is $145.97B and the low estimate is $121.6B.
